Johnson & Johnson
I · AI Analysis
The brief
J&J operates in two main areas: Innovative Medicine (prescription drugs for cancer, immunology, neuroscience, and other diseases) and MedTech (medical devices like surgical instruments, artificial joints, contact lenses under the ACUVUE brand, and robotic surgery systems) [Company Overview]. They sell to hospitals, doctors, pharmacies, and retailers worldwide [Company Overview].
Johnson & Johnson is a massive American healthcare company that makes both medicines (for cancer, immune diseases, etc.) and medical devices (surgical tools, contact lenses, artificial joints). With $96.4 billion in annual revenue and over 138,000 employees, it's one of the world's largest and most established healthcare firms [Company Overview].
Johnson & Johnson is in very strong financial shape with high profit margins and manageable debt.
Sentinellis health
10/10
Financially healthy
Market capitalisation
$565.1B
Revenue (TTM)
$96.4B
II · Recent news
What moved
1 stories · ranked by relevance
- macro2026-04-16
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.7% – Time to Sell?
Ticker Report
Premium · Free with any account
The Piotroski score of 3 out of 9 is concerning — this metric measures financial strength trends, and a low score suggests weakening fundamentals or operational efficiency compared to prior periods, though the specific drivers are not detailed in the data [Yahoo Finance].
Risks
3
Opportunities
3
Red flags
2
Leadership
10
7 more findings in the full report — free with any account.
Unlock the full Johnson & Johnson analysis
Create a free account to access the complete AI-generated report with inline citations.
- 3 risks, 3 opportunities and 2 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare or comparable health
Want this for your watchlist?